Richard Whitley to Research Design
This is a "connection" page, showing publications Richard Whitley has written about Research Design.
Connection Strength
0.216
-
Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996 Jan; 29(1):67-8.
Score: 0.105
-
Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res. 1997 Jan; 33(2):73-85.
Score: 0.028
-
Evaluation of new anti-infective drugs for the treatment of infection with human immunodeficiency virus. The European Working Party of the European Society of Clinical Microbiology and Infectious Diseases. Clin Infect Dis. 1993 Oct; 17(4):794-801.
Score: 0.023
-
Evaluation of new anti-infective drugs for the treatment of viral encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S195-9.
Score: 0.021
-
Design of therapeutic studies in herpes simplex encephalitis. Lancet. 1985 Feb 02; 1(8423):284-5.
Score: 0.012
-
Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 01; 1(8279):1013.
Score: 0.010
-
Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S182-8.
Score: 0.005
-
Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S189-94.
Score: 0.005
-
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S200-5.
Score: 0.005